Related Experiment Videos
Macrovascular disease in diabetes: current status
P Roesen1, P Ferber, D Tschoepe
1German Diabetes Research Institute, Heinrich Heine University, Duesseldorf, Germany.
Summary
Diabetes patients face serious macrovascular complications, leading to significant health burdens. Early detection and a multimodal therapeutic approach focusing on inflammation are crucial for better patient outcomes.
Area of Science:
- Cardiovascular Medicine
- Endocrinology
- Pathophysiology
Background:
- Macrovascular complications significantly impact diabetes patient prognosis and contribute to the disease's socio-economic burden.
- Current morbidity and mortality rates suggest inadequate care for diabetes patients, possibly due to late diagnosis and unrecognised comorbidities.
- Endothelial dysfunction, termed "functional atherosclerosis," and blood hyperresponsiveness are key issues in diabetes progression.
Purpose of the Study:
- To explore novel experimental aspects of early atherosclerosis development in diabetes.
- To investigate the role of inflammation as a driving force in the evolution of complex diabetic lesions.
- To highlight the interconnectedness of inflammation, atherogenesis, and thrombogenesis via adhesion molecules.
Main Methods:
- Focus on experimental models of early atherosclerosis in diabetes.
- Analysis of the role of inflammation and adhesion molecules in disease progression.
- Discussion of genomic detection for risk identification and personalized drug targeting.
Main Results:
- Inflammation is identified as a key pathogenetic factor in early atherosclerosis in diabetes.
- Soluble and cellular adhesion molecules critically link inflammation, atherogenesis, and thrombogenesis.
- Genomic detection offers potential for early risk identification and tailored interventions.
Conclusions:
- A multimodal therapeutic strategy, tailored to individual patient needs and incorporating evidence-based interventions, is essential for reducing endpoints.
- Early identification of high-risk individuals through genomic detection can guide targeted drug interventions.
- Recognizing diabetes as a vascular disease necessitates a comprehensive approach to managing its complications.